BLOG


Co-Poker travelled to Milan to inspire transforming disruption into opportunity

BY INFONOMIA on 08 / 01 / 2015

Once more, Co-Society was invited to be part of C2 Sparks, a workshop on co-innovation touring different Europeans capitals. This time Milan was the destination, and there we went with our Co-Poker to participate in an event that was all about a inspiration, experimentation, connection and celebration and where a select group of thinkers, influencers and business executives gathered to explore how we can transform disruption into opportunities.

Brand-new branding: leave your island and be part of an ecosystem

BY INFONOMIA on 01 / 01 / 2015

If once upon a time brands were islands, today companies are increasingly seeing the advantages of turning their brands in a gravitational center of an ecosystem, orchestrating many of the actions taken by the partners and playing the leading role in building and maintaining trust among all parties.

Co-Session #19 Big Data (II): The creativity factor

BY INFONOMIA on 26 / 12 / 2014

Holding this Co-Session in Barcelona’s Design Hub gave us two advantages, which it would have been silly not to exploit. Firstly, the location in the new building of Materfad, Centro de Materiales de Barcelona, dedicated to technological research and investigation in the field of new materials. Secondly, the concurrence in time and place with the annual meeting of the Art Directors Club of Europe (ADC*E). Both formed part of the day’s programme.

Co-Session #19 Big Data (I): Evidence-Based Business

BY INFONOMIA on 21 / 12 / 2014

Big data is the expression of the moment, which is why now is exactly the right time to work out what that means. Big data is at the pinnacle of Gartner’s Hype Cycle of Emerging Technologies, and right now is when we should be asking just what we should be doing with it. Co-Society dedicated Co-Session #19 to the response to this question.

Pfizer Legal Alliance: a co- program equally praised and called into question

BY INFONOMIA on 14 / 12 / 2014

Considered for the last five years the most innovative initiative to transform the way legal services are delivered and valued, the Pfizer Legal Alliance (PLA) was designed as a long-term collaborative partnership between pharmaceutical Pfizer and 19 law firms. PLA was based on the idea that traditional competitive “beauty contests” between law firms and billable hours approach create a barrier to client–firm relationships and negatively affects the quality of legal outcomes.

This site may use some "cookies" to improve your experience when navigating. Before continuing to navigate on our web page, we recommend you read the Policy on Cookies.